Search

Your search keyword '"Collee J.M."' showing total 49 results

Search Constraints

Start Over You searched for: Author "Collee J.M." Remove constraint Author: "Collee J.M."
49 results on '"Collee J.M."'

Search Results

1. Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families

2. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

4. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

5. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

6. Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study

7. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

8. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

9. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

10. Breast cancer risk genes - Association analysis in more than 113,000 women.

11. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

12. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

13. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

14. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

15. Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity

16. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

17. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of BRCA1 and BRCA2 mutation carriers.

18. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

19. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

20. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

21. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (vol 5, 4999, 2014)

22. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

23. Shared heritability and functional enrichment across six solid cancers.

24. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4).

25. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

26. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

27. Refined histopathological predictors of BRCA1\ud and BRCA2 mutation status: a large-scale analysis\ud of breast cancer characteristics from the BCAC,\ud CIMBA, and ENIGMA consortia

28. Improved Overall Survival after Contralateral Risk-Reducing Mastectomy in Brca1/2 Mutation Carriers with a History of Unilateral Breast Cancer: A Prospective Analysis

30. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

31. MicroRNA related polymorphisms and breast cancer risk

33. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

34. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

35. Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis

36. Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction

37. Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers

39. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche

40. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

41. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

42. Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

43. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.

44. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

45. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics

Catalog

Books, media, physical & digital resources